These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1617 related items for PubMed ID: 17082219

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Long-term followup of a randomized study of locally advanced prostate cancer treated with combined orchiectomy and external radiotherapy versus radiotherapy alone.
    Granfors T, Modig H, Damber JE, Tomic R.
    J Urol; 2006 Aug; 176(2):544-7. PubMed ID: 16813885
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer.
    Frank SJ, Pisters LL, Davis J, Lee AK, Bassett R, Kuban DA.
    J Urol; 2007 Jun; 177(6):2151-6; discussion 2156. PubMed ID: 17509305
    [Abstract] [Full Text] [Related]

  • 6. Radiotherapy after radical prostatectomy: does transient androgen suppression improve outcomes?
    King CR, Presti JC, Gill H, Brooks J, Hancock SL.
    Int J Radiat Oncol Biol Phys; 2004 Jun 01; 59(2):341-7. PubMed ID: 15145146
    [Abstract] [Full Text] [Related]

  • 7. Long-term results of adjuvant hormonal therapy plus radiotherapy following radical prostatectomy for patients with pT3N0 or pT3N1 prostate cancer.
    Miyake H, Sakai I, Harada K, Hara I, Eto H.
    Int J Urol; 2004 Jun 01; 11(6):397-401. PubMed ID: 15157209
    [Abstract] [Full Text] [Related]

  • 8. Androgen suppression plus radiation versus radiation alone for patients with stage D1/pathologic node-positive adenocarcinoma of the prostate: updated results based on national prospective randomized trial Radiation Therapy Oncology Group 85-31.
    Lawton CA, Winter K, Grignon D, Pilepich MV.
    J Clin Oncol; 2005 Feb 01; 23(4):800-7. PubMed ID: 15681524
    [Abstract] [Full Text] [Related]

  • 9. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.
    Potosky AL, Davis WW, Hoffman RM, Stanford JL, Stephenson RA, Penson DF, Harlan LC.
    J Natl Cancer Inst; 2004 Sep 15; 96(18):1358-67. PubMed ID: 15367568
    [Abstract] [Full Text] [Related]

  • 10. Retrospective comparison of external beam radiotherapy and radical prostatectomy in high-risk, clinically localized prostate cancer.
    Arcangeli G, Strigari L, Arcangeli S, Petrongari MG, Saracino B, Gomellini S, Papalia R, Simone G, De Carli P, Gallucci M.
    Int J Radiat Oncol Biol Phys; 2009 Nov 15; 75(4):975-82. PubMed ID: 19395188
    [Abstract] [Full Text] [Related]

  • 11. Long-term outcomes of 60 Gy conventional radiotherapy combined with androgen deprivation for localized or locally advanced prostate cancer.
    Hashine K, Numata K, Azuma K, Sumiyoshi Y, Kataoka M.
    Jpn J Clin Oncol; 2005 Nov 15; 35(11):655-9. PubMed ID: 16275680
    [Abstract] [Full Text] [Related]

  • 12. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
    Da Pozzo LF, Cozzarini C, Briganti A, Suardi N, Salonia A, Bertini R, Gallina A, Bianchi M, Fantini GV, Bolognesi A, Fazio F, Montorsi F, Rigatti P.
    Eur Urol; 2009 May 15; 55(5):1003-11. PubMed ID: 19211184
    [Abstract] [Full Text] [Related]

  • 13. High-dose-rate iridium-192 afterloading therapy combined with external beam radiotherapy for T1c-T3bN0M0 prostate cancer.
    Jo Y, Hiratsuka J, Fujii T, Takenaka A, Fujisawa M.
    Urology; 2004 Sep 15; 64(3):556-60. PubMed ID: 15351592
    [Abstract] [Full Text] [Related]

  • 14. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin.
    Bolla M, Gonzalez D, Warde P, Dubois JB, Mirimanoff RO, Storme G, Bernier J, Kuten A, Sternberg C, Gil T, Collette L, Pierart M.
    N Engl J Med; 1997 Jul 31; 337(5):295-300. PubMed ID: 9233866
    [Abstract] [Full Text] [Related]

  • 15. Surgery versus implant for early prostate cancer: results from a single institution, 1992-2005.
    Colberg JW, Decker RH, Khan AM, McKeon A, Wilson LD, Peschel RE.
    Cancer J; 2007 Jul 31; 13(4):229-32. PubMed ID: 17762756
    [Abstract] [Full Text] [Related]

  • 16. The role of endocrine therapy in the management of local and distant recurrence of prostate cancer following radical prostatectomy or radiation therapy.
    Mayer FJ, Crawford ED.
    Urol Clin North Am; 1994 Nov 31; 21(4):707-15. PubMed ID: 7974899
    [Abstract] [Full Text] [Related]

  • 17. External beam radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate carcinoma.
    Algan O, Fosmire H, Hynynen K, Dalkin B, Cui H, Drach G, Stea B, Cassady JR.
    Cancer; 2000 Jul 15; 89(2):399-403. PubMed ID: 10918172
    [Abstract] [Full Text] [Related]

  • 18. Effectiveness of adjuvant intermittent endocrine therapy following neoadjuvant endocrine therapy and external beam radiation therapy in men with locally advanced prostate cancer.
    Yamanaka H, Ito K, Naito S, Tsukamoto T, Usami M, Fujimoto H, Matsuoka N, Fukui I, Harada M, Ohashi Y, Kotake T, Kakizoe T.
    Prostate; 2005 Apr 01; 63(1):56-64. PubMed ID: 15468166
    [Abstract] [Full Text] [Related]

  • 19. Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: data from cancer of the prostate strategic urologic research endeavor.
    Grossfeld GD, Li YP, Lubeck DP, Broering JM, Mehta SS, Carroll PR.
    J Urol; 2002 Aug 01; 168(2):530-5. PubMed ID: 12131303
    [Abstract] [Full Text] [Related]

  • 20. Locally advanced prostate cancer: effective treatments, but many adverse effects.
    Prescrire Int; 2013 Jan 01; 22(134):18-20, 22-3. PubMed ID: 23367679
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 81.